Study Stopped
Insufficient patient volume
The Assessment of Oxidative Stress Markers and the Development of Atrial Fibrillation After Cardiac Surgery
POAF
1 other identifier
observational
100
1 country
2
Brief Summary
The purpose of the investigators study is to investigate the correlation between naturally occurring chemicals, called reactive oxygen species (ROS), in the blood of human patients and the development of an abnormal heart rhythm, known as atrial fibrillation (AF). The development of atrial fibrillation is associated with increased medical problems like stroke. Many factors seem to cause the development of AF, and this rhythm occurs frequently after open heart surgery. When patients develop AF after cardiac surgery they are at increased risk for cognitive changes, infections, the development of kidney failure, and increased length of hospitalization. ROS are chemicals in blood and tissues that tend to cause microscopic blood vessel and heart damage. These chemicals occur naturally as the result of chemical reactions that occur in states of stress and inflammation, like tissue trauma and as the result of smoking. Patients who undergo cardiac surgery may have higher levels of ROS because of their underlying medical conditions. In addition, the organized tissue trauma that occurs in the setting of surgery may serve to increase ROS levels further. In turn, the higher ROS levels may put patients at even higher risk for the development of AF. The investigators believe that increased levels of ROS may help potentiate a patient's development of AF. Accordingly the investigators aim to measure ROS levels before and after surgery to see if there are particular levels that predict the development of this abnormal heart rhythm. By developing a better knowledge of the relationship between ROS and AF, the investigators hope to better understand another possible method of detecting patients who are at the highest risk of developing AF before it occurs after surgery. If these patients are better identified, this may eventually lead to medical treatment to prevent AF; and hopefully this will result in a decrease of the malicious effects that result from developing this abnormal heart rhythm.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2008
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 14, 2009
CompletedFirst Posted
Study publicly available on registry
February 18, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedApril 23, 2014
April 1, 2014
5 years
January 14, 2009
April 21, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Baseline of oxidative stress markers prior to subjects undergoing cardiac surgery
up to 24 hours pre-op
To evaluate the ability of oxidative stress markers to predict postoperative atrial fibrillation in subjects undergoing cardiac surgery
Day 1 post-op
To evaluate the ability of oxidative stress markers to predict postoperative atrial fibrillation in subjects undergoing cardiac surgery
When develop Atrial Fibrillation or upon discharge from hospital, usually within 1 week post-op
Study Arms (1)
Post operative atrial fibrillation
To evaluate the ability of oxidative stress markers to predict postoperative atrial fibrillation in subjects undergoing cardiac surgery.
Eligibility Criteria
The target population of this study is all patients who will undergo cardiac surgery. There is no particular age range, but subjects less than 18 years of age will be omitted because of the rarity of AF in this population. The target number of subjects will be 100.
You may qualify if:
- Age ≥18 years
- Sinus rhythm at the time of enrollment as documented by ECG, telemetry, or Holter monitoring
- Scheduled for an open heart surgery
- Able to provide informed consent
You may not qualify if:
- Systemic inflammatory diseases (e.g., collagen vascular diseases, infections)
- Malignant neoplasms
- Hyperthyroidism
- Uncontrolled hypertension (blood pressure \> 180/100 at rest) on medications
- An illness that might result in death within 1 year
- Implanted devices for designed for active management of atrial arrhythmias by pacing or defibrillation
- Current illicit drug use
- Current ethanol abuse
- Presence of paroxysmal, persistent, or permanent atrial fibrillation at the time of enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Illinois at Chicago
Chicago, Illinois, 60612, United States
Advocate Christ Medical Center
Oak Lawn, Illinois, 60453, United States
Biospecimen
Approximately 10- 15 ml of blood will be drawn from subjects. Blood samples will be separated into plasma and serum to measure the oxidative stress markers.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel C Dudley, MD. PhD
University of Illinois at Chicago
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 14, 2009
First Posted
February 18, 2009
Study Start
April 1, 2008
Primary Completion
April 1, 2013
Study Completion
April 1, 2013
Last Updated
April 23, 2014
Record last verified: 2014-04